Molecular Diagnostics

Genetic Test Discovered for Predicting Cancer Recurrence
Treatment failure, due to drug resistance, still remains a major obstacle for more effective anti-cancer therapy and personalized medicine. In estrogen-receptor-positive (ER (+)) breast cancer, approximately 40% to 50% of patients eventually develop tamoxifen-resistance. More...04 Oct 2017

New Markers Revealed for Severe Multiple Sclerosis
Multiple Sclerosis (MS) is a chronic condition that affects an estimated 2.3 million people worldwide. In MS, the sheath covering nerve fibers in the brain and spinal cord becomes damaged, slowing or blocking electrical signals from the brain reaching the eyes, muscles, and other parts of the body. More...03 Oct 2017


Discovered Inherited Syndrome Predisposes Body to Cancer
The syndrome was found and characterized by studying patients with biallelic mutations (mutations in both inherited gene copies) in the FANCM gene. These mutations predisposed the body to development of tumors and to hypersensitivity to and rejection of chemotherapy treatments. Contrary to what has been thought, the study suggests that mutations in the FANCM gene does not cause Fanconi anemia, a rare disease that affects ~ 1 of every 100,000 children. More...02 Oct 2017


Genetic Cause of Peritoneal Mesothelioma Discovered
Mesothelioma is a rare and aggressive tumor that, in many cases, results from exposure to asbestos, but other causes of the disease have emerged, including treatment with high-intensity therapeutic radiation and, more recently, an inherited genetic mutation. More...28 Sep 2017

Blood Test Predicts Treatments for Lung Cancer Patients
Traditionally, lung cancer diagnosis has relied solely on lung biopsies, an invasive procedure which many patients are too unwell to tolerate. A simple test, which can detect gene mutations in tumor DNA from blood samples, is giving new choices to lung cancer patients with faster diagnosis and improved access to life changing drugs. More...27 Sep 2017
In Other News
Type 2 Diabetes Misdiagnosed in African Americans
Checklist Developed for Early Identification of Infants with SCID
Protein Network Mutations Impact Revealed in Bowel Cancer
Genes behind Gestation Length and Preterm Delivery Identified
Combination Liquid Biopsy Diagnoses Early Cancer
Liquid Biopsy Test Launched for NRAS Mutations
Blood Test Predicts Immunotherapy Efficacy
Early Stage Melanoma Identified by Simple Blood Test
Direct Spectroscopy Used for Diagnosis of Neurodegenerative Disorders
Tumor Marker Levels Serve As Indicators of Disease Progression
Newly Emerged Superbug Discovered
Risk of Preeclampsia Linked to Fetal Genes
New Diagnostic Test Improves Detection of Tuberculosis
Gene Related to Abnormal Brain Development Identified
Gene Mutation Increases Risk of Neurodevelopmental Disorders
Serum Level Measurements Improve Disease Risk Prediction
Early Stage Cancer CTCs Indicators of Poor Prognosis
Antibacterial Resistance Revealed in Women with UTIs
Molecular Blood Test Could Diagnose Ischemic Stroke
Side Effects of BP Drugs Genetically Determined
Blood Test Predicts Prostate Tumor Resistance
Liquid Biopsy Panel Yields Complete Molecular Profile
Novel PCR Test Detects H. Pylori Drug Resistance
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.








